The first PSC Forum meeting was held on Thursday, October 19, 2017 in Washington D.C. 63 people attended PSC Forum 1. Of those, 60 people attended in person and 3 attended remotely.
Materials
Presentations
Session I: Overview & PSC Project Updates
Veronica Miller, Forum for Collaborative Research
Keith Lindor, Arizona State University
Rob Myers, Gilead Sciences, Inc
PSC Project & Working Group Updates
PSC-Specific ICD-10 Code
Ricky Safer, PSC Partners Seeking a Cure
Quality of Life Measure for PSC
Martine Walmsley, PSC Support
PSC Inclusion/ Exclusion Criteria and iPSCsg Update
Gideon Hirschfield, University of Birmingham
PSC Patient Databases
Rachel Gomel, PSC Partners Seeking a Cure
Session II: Regulatory Perspectives
FDA: PSC Pathways and Endpoints
Suna Seo, U.S. Food and Drug Administration
Elmer Schabel, European Medicines Agency
Session III: Clinical Trial Management Session
Lessons Learned: Simtuzumab Program
Rob Myers, Gilead Sciences, Inc.